Update shared on 14 Dec 2025
Fair value Decreased 0.39%Analysts have nudged their price target for RHI Magnesita slightly lower to approximately €24.90 from about €25.01, citing expectations for more moderate revenue growth, partly offset by improving profit margins and a lower future price to earnings multiple.
Valuation Changes
- Fair Value: edged down slightly from €25.01 to €24.91 per share, reflecting a modest reduction in the intrinsic valuation estimate.
- Discount Rate: risen marginally from 10.58% to 10.66%, implying a slightly higher required return on equity.
- Revenue Growth: lowered from about 2.21% to around 1.63% annually, signalling more cautious expectations for top line expansion.
- Net Profit Margin: increased from roughly 5.53% to about 6.24%, indicating expectations for improved profitability.
- Future P/E: reduced from about 8.83x to roughly 7.85x, suggesting a lower valuation multiple applied to forecast earnings.
Have other thoughts on RHI Magnesita?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
AnalystLowTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystLowTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystLowTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.